Drugs / IR199
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07707531 | Jun 2026 → Apr 2027 expected | gastric cancer, malignant pancreatic neoplasm | Huashan Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IR199 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07707531 ↗ |